When to end a lock down? How fast must vaccination campaigns proceed in order to keep health costs in check?

@article{Gros2022WhenTE,
  title={When to end a lock down? How fast must vaccination campaigns proceed in order to keep health costs in check?},
  author={Claudius Gros and Thomas Czypionka and Daniel Gros},
  journal={Royal Society Open Science},
  year={2022},
  volume={9}
}
We propose a simple rule of thumb for countries which have embarked on a vaccination campaign while still facing the need to keep non-pharmaceutical interventions (NPI) in place because of the ongoing spread of SARS-CoV-2. If the aim is to keep the death rate from increasing, NPIs can be loosened when it is possible to vaccinate more than twice the growth rate of new cases. If the aim is to keep the pressure on hospitals under control, the vaccination rate has to be about four times higher… 

Figures from this paper

References

SHOWING 1-10 OF 59 REFERENCES

Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves

Using the age-stratified model and curated epidemiological and vaccination data, it is quantified at which pace European countries can lift restrictions without overwhelming their health-care systems.

Estimating real-world COVID-19 vaccine effectiveness in Israel

Using counts of positive and hospitalized cases of vaccinated individuals, sensitive estimations of the vaccine effectiveness are provided by correcting to daily case incidence, finding high effectiveness of 66-85% in reducing SARS-CoV-2 positive cases and over 90%" in reducing severe hospitalizations.

Prioritizing COVID-19 vaccination by age

  • M. CastroB. Singer
  • Medicine, Political Science
    Proceedings of the National Academy of Sciences
  • 2021
On March 11, 2020, the World Health Organization declared the spread of a novel coronavirus to be a pandemic. Subsequently, and only 272 d afterward, the Pfizer vaccine started to be applied in the

Patterns of COVID-19 pandemic dynamics following deployment of a broad national immunization program

Evidence for the real-life effectiveness of a national vaccination campaign in Israel on the pandemic dynamics is demonstrated, with a larger and earlier decrease among older individuals, and more evident in early- vaccinated compared to late-vaccinated cities.

High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in Long-Term Care Facilities

It is estimated that once more than 70% of the LTCFs population were fully vaccinated, 74% (58%−81%, 90% CI) of COVID-19 deaths and 75% (36%−86%) of all documented infections were prevented.

High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in Long-Term Care Facilities

It is estimated that once more than 70% of the LTCFs population were fully vaccinated, 74% (58%-81%, 90% CI) of COVID-19 deaths and 75% (36%-86%) of all documented infections were prevented and detectable transmission was reduced up to 90%.

Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021

The results support ongoing vaccination campaigns and support the real-world impact of vaccines on COVID-19 related outcomes.

Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID‐19

This model suggests substantial reductions in hospital and ICU admissions will not occur until late March and into April 2021 and an inflection point, when 50% of the adult population has been vaccinated, may be a useful point for re‐evaluating vaccine prioritisation.

Covid-19: Oxford vaccine is up to 90% effective, interim analysis indicates

The covid-19 vaccine candidate developed by the University of Oxford is 90% effective when a person is initially given a half dose followed by a full dose, interim phase III trial results show. The
...